Advertisement

Topics

GlaxoSmithKline to Shut Down Shanghai R&D, Shift Programs to Global R&D Hub in the U.S.

20:00 EDT 3 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: GlaxoSmithKline to Shut Down Shanghai R&D, Shift Programs to Global R&D Hub in the U.S.

NEXT ARTICLE

More From BioPortfolio on "GlaxoSmithKline to Shut Down Shanghai R&D, Shift Programs to Global R&D Hub in the U.S."

Quick Search
Advertisement